(2E)-3-[4-(Dimethylamino)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one
![]() |
- $180 - $838
- Product name: (2E)-3-[4-(Dimethylamino)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one
- CAS: 65786-13-2
- MF: C17H17NO2
- MW: 267.32
- EINECS:
- MDL Number:MFCD00102441
- Synonyms:(2E)-3-[4-(Dimethylamino)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one;(2E)-2-{-3-[4-(Dimethylamino)phenyl]prop-2-enoyl}phenol;2-Propen-1-one, 3-[4-(dimethylamino)phenyl]-1-(2-hydroxyphenyl)-, (2E)-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- SynQuest Laboratories
Package
- 1G
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0002198
- Product description3-[4-(DIMETHYLAMINO)PHENYL]-1-(2-HYDROXYPHENYL)PROP-2-EN-1-ONE 95.00%
- Packaging1G
- Price$723.03
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12045898
- Product description(E)-3-(4-(Dimethylamino)phenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one 97%
- Packaging5g
- Price$838
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4956-1-X5
- Product description(2E)-3-[4-(Dimethylamino)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one
- Packaging1g
- Price$180
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0002198 | 3-[4-(DIMETHYLAMINO)PHENYL]-1-(2-HYDROXYPHENYL)PROP-2-EN-1-ONE 95.00% | 1G | $723.03 | 2021-12-16 | Buy |
Crysdot | CD12045898 | (E)-3-(4-(Dimethylamino)phenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one 97% | 5g | $838 | 2021-12-16 | Buy |
SynQuest Laboratories | 4956-1-X5 | (2E)-3-[4-(Dimethylamino)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one | 1g | $180 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|